On Thursday, San Francisco-based R&D cloud software company Benchling announced that it has acquired Belfast-based Ovewatch Research, a software company for customers working on preclinical biopharma ...
Launching with HighRes, Automata, Ginkgo Bioworks, Celltrio, Opentrons, and Hamilton, Benchling Automation brings an open ecosystem approach to lab-in-the-loop SAN FRANCISCO, May 28, 2026 /PRNewswire/ ...
Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.
Email and a smarter notebook might be enough for handling communication for projects or experiments inside a team in a lab in some university basement. But when you have around 200 scientists working ...
After picking up $200 million just over six months ago, Benchling isn’t sitting still. The cloud-based R&D platform developer collected another $100 million to help power its global expansion plans.
After the last two decades of consumer Internet and mobile innovation, is biotech or bioinformatics the next wave? There are a handful of San Francisco-based startups that cross the bridge between the ...
Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500 scientists from 30 teams. Benchling is ...
SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...
Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results